HIV & AIDS

Impaired T cell function precedes loss of natural HIV control

HIV is a master of evading the immune system, using a variety of methods to prevent the body from being able to find and kill it. The vast majority of people living with HIV require daily medication to suppress the virus ...

Diseases, Conditions, Syndromes

A promising two-punch therapy for Langerhans cell histiocytosis

Langerhans cell histiocytosis (LCH) is a rare cancer involving dendritic cells, a type of white blood cell that usually helps defend against infections. The current standard of care for LCH, chemotherapy, cures fewer than ...

Oncology & Cancer

New research optimizes body's own immune system to fight cancer

A groundbreaking study led by engineering and medical researchers at the University of Minnesota Twin Cities shows how engineered immune cells used in new cancer therapies can overcome physical barriers to allow a patient's ...

Oncology & Cancer

New inhibitor found to combat drug-resistant cancer cells

A new substance could improve the treatment of persistent cancers. Researchers at Martin Luther University Halle-Wittenberg (MLU) and the University of Greifswald have developed a new inhibitor that makes drug-resistant tumor ...

Oncology & Cancer

Cancer: A new killer lymphocyte enters the ring

Treatments for beating tumors are mainly based on CD8 T lymphocytes, which specialize in detecting and eliminating intracellular infections and in killing cancer cells. A large proportion of patients, however, do not respond ...

page 5 from 14